A decade of discovery: tempus supported almost 1,500 research projects in 10 years

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced its participation in almost 1,500 research projects in just the last ten years. this milestone highlights tempus' ongoing commitment to accelerating scientific discovery and delivering data-driven insights that improve patient outcomes. since its founding in 2015, tempus has partnered with leading academic institutions, communit.
TEM Ratings Summary
TEM Quant Ranking